Stay updated with breaking news from Tim Mccarthy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phase 2/3 adaptive clinical trial of P140 in Lupus to commence following FDA meeting 19th June 2023 - 9:43 am ImmuPharma PLC , the specialist drug discovery and development... | June 19, 2023
ImmuPharma PLC - London-based drug discovery and development company - Will start phases two and three of the clinical trial for Lupuzor in the seocnd half of 2023, following talks with the US Food... | June 19, 2023
ImmuPharma PLC (AIM:IMM, OTC:IMMPF) is set to initiate a Phase 2/3 adaptive clinical trial for its P140 (Lupuzor) drug in systemic lupus erythematosus...
/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...
/cloudfront-us-east-1.images.arcpublishing.com/advancelocal/O4V535VA6REFTG4BQ4J52Y6AY4.JPG)
Smooth ice and more public skates are just a few of the changes expected at Serpentini Arena-Winterhurst.